DXS INTERNATIONAL PLC (AQSE: DXSP) Result of AGM

Summary by AI ^BETAClose X

DXS International plc announced that all resolutions were passed at its Annual General Meeting, with Resolution 1 receiving 100% of votes for and Resolutions 2 through 6 receiving at least 99.77% of votes for, indicating strong shareholder support. The company's CEO provided an update on progress, and the presentation is available on the company's website.

Disclaimer*

19 December 2025

DXS INTERNATIONAL PLC (AQSE: DXSP)

Result of DXS AGM 2025

The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's Annual General Meeting ("AGM") held yesterday were duly passed.

All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below.

Resolution	Votes For *	%	Votes Against	%	Votes Withheld **

Resolution 1	14,681,963	100.00	0	0.00	0
Resolution 2	14,647,713	99.77	34,250	0.23	0
Resolution 3	14,671,963	99.97	5,000	0.03	5,000
Resolution 4	14,671,963	99.97	5,000	0.03	5,000
Resolution 5	14,676,963	99.97	5,000	0.03	0
Resolution 6	14,671,963	99.97	5,000	0.03	5,000

* Includes discretionary votes

** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" any of the resolutions

During the AGM, the Company's CEO, David Immelman, provided an update on DXS’s progress. The Presentation is available for download from the Company's website at https://www.dxs-systems.co.uk/corporate-documents.php

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman DXS International plc www.dxs-systems.com	01252 719800
AQSE Corporate Broker and Corporate Advisor Hybridan LLP Claire Louise Noyce	020 3764 2341

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

Attachment